Generic Name: Naltrexone
Naltrexone, in low doses such as 3mg to 4.5mg, has been found to boost the immune system in MS, autoimmune diseases, and central nervous system disorders. Naltrexone was FDA-approved in 1985 for the management of alcohol dependence and opioid dependence at 50mg doses.
Read more...
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Slow my MS progress | 199 |
|
|
|
|
|
54 |
| Other | 28 |
|
|
|
10 | ||
| Fatigue | 16 |
|
|
|
6 | ||
| Stiffness/Spasticity | 14 |
|
|
|
3 | ||
| Mobility | 13 |
|
|
|
5 | ||
| Bladder problems | 9 |
|
1 |
See all 261 patients currently taking Low Dose Naltrexone (LDN)
Mouse over the table for more information
Top 10 dosages based on patients currently taking Low Dose Naltrexone (LDN). See all 21 dosages ►
| 3.5 mg all the time (24/7) | daily | 0.4 mg daily | 1 daily | 1 mg daily | 1.5 mcg daily | 1.5 mg daily | 1.5 mL daily | 1.75 mg daily | 2 mg daily | 2 mL daily | 4.5 mg | 2.5 mg daily | 3 mg daily | 3.5 mg daily | 4 mg daily | 4.25 mg daily | 4.5 mg daily | 5 mg daily | 6 mg daily | 9 mg daily | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1
|
6
|
1
|
1
|
2
|
1
|
11
|
1
|
1
|
3
|
1
|
1
|
1
|
65
|
10
|
9
|
1
|
141
|
2
|
1
|
1
|
||
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Did not seem to work
|
21 | 46% |
|
|
Other
|
11 | 24% |
|
|
Side effects too severe
|
10 | 22% |
|
|
Doctor's advice
|
8 | 17% |
|
|
Personal research
|
3 | 7% |
|
|
Expense
|
3 | 7% |
|
|
Course of treatment ended
|
2 | 4% |
|
|
Not indicated
|
1 | 2% |
|
See all 46 patients who’ve stopped taking Low Dose Naltrexone (LDN)
Report created on November 23, 2009.